Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Randomized Phase 2 Clinical Trial to Assess Safety and Tolerability of RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/Aids and Pulmonary Tuberculosis

NCT03281226 is registered in ClinicalTrials.gov with Fundação de Medicina Tropical Dr. Heitor Vieira Dourado as lead sponsor.

NCT NCT03281226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03281226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Randomized Phase 2 Clinical Trial to Assess Safety and Tolerability of RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/Aids and Pulmonary Tuberculosis
Lead sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Phase
Phase 2
Overall status
Unknown status
Start date
December 7, 2016
Completion date
December 31, 2019
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids, tuberculosis, pulmonary